Use of lorlatinib subsequent to crizotinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience

South Asian J Cancer. 2019 Oct-Dec;8(4):211. doi: 10.4103/sajc.sajc_169_19.
No abstract available